Litcius/Paper detail

Immune Checkpoint Inhibitors plus Anti-VEGF/Tyrosine Kinase Inhibitors Combined with TACE (Triple Therapy) in Unresectable Hepatocellular Carcinoma

Masatoshi Kudo

2024Liver Cancer15 citationsDOIOpen Access PDF

Topics & Concepts

Hepatocellular carcinomaMedicineTriple-negative breast cancerOncologyImmune checkpointInternal medicineVEGF receptorsCancer researchImmunotherapyCancerBreast cancerHepatocellular Carcinoma Treatment and PrognosisCancer Mechanisms and TherapyCancer, Hypoxia, and Metabolism
Immune Checkpoint Inhibitors plus Anti-VEGF/Tyrosine Kinase Inhibitors Combined with TACE (Triple Therapy) in Unresectable Hepatocellular Carcinoma | Litcius